These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12769609)

  • 1. Targeting neuronal nicotinic receptors: a path to new therapies.
    Bencherif M; Schmitt JD
    Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):349-57. PubMed ID: 12769609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
    Newhouse PA; Potter A; Levin ED
    Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic acetylcholine receptors as drug targets.
    Hogg RC; Bertrand D
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):123-30. PubMed ID: 15078187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
    Hogg RC; Bertrand D
    Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities.
    Manetti D; Bellucci C; Chiaramonte N; Dei S; Teodori E; Romanelli MN
    Future Med Chem; 2018 Feb; 10(4):433-459. PubMed ID: 29451400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic promise of positive allosteric modulation of nicotinic receptors.
    Uteshev VV
    Eur J Pharmacol; 2014 Mar; 727():181-5. PubMed ID: 24530419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.
    Grupe M; Grunnet M; Bastlund JF; Jensen AA
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):187-200. PubMed ID: 25441336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
    Chatterjee S; Bartlett SE
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):60-76. PubMed ID: 20201817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.
    Dwoskin LP; Crooks PA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):395-402. PubMed ID: 11454899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Nicotinic and Muscarinic Receptors on Synaptic Plasticity and Neurological Diseases.
    Fuenzalida M; Pérez MÁ; Arias HR
    Curr Pharm Des; 2016; 22(14):2004-14. PubMed ID: 26818867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
    Holladay MW; Dart MJ; Lynch JK
    J Med Chem; 1997 Dec; 40(26):4169-94. PubMed ID: 9435889
    [No Abstract]   [Full Text] [Related]  

  • 12. Diversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release.
    Alkondon M; Rocha ES; Maelicke A; Albuquerque EX
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1460-71. PubMed ID: 8819534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
    Jonnala RR; Buccafusco JJ
    J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The wonderland of neuronal nicotinic acetylcholine receptors.
    Bertrand D; Terry AV
    Biochem Pharmacol; 2018 May; 151():214-225. PubMed ID: 29248596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nicotine acetylcholine receptors and neuropsychiatric disorders].
    Vázquez-Palacios G; Bonilla-Jaime H
    Rev Neurol; 2004 Dec 16-31; 39(12):1146-60. PubMed ID: 15625635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain neuronal nicotinic receptors as new targets for drug discovery.
    Gotti C; Riganti L; Vailati S; Clementi F
    Curr Pharm Des; 2006; 12(4):407-28. PubMed ID: 16472136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors.
    Molgó J; Aráoz R; Benoit E; Iorga BI
    Expert Opin Drug Discov; 2013 Oct; 8(10):1203-23. PubMed ID: 23919818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function.
    Albuquerque EX; Alkondon M; Pereira EF; Castro NG; Schrattenholz A; Barbosa CT; Bonfante-Cabarcas R; Aracava Y; Eisenberg HM; Maelicke A
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1117-36. PubMed ID: 9067295
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotine-induced Ca2+-myristoyl switch of neuronal Ca2+ sensor VILIP-1 in hippocampal neurons: a possible crosstalk mechanism for nicotinic receptors.
    Zhao C; Anand R; Braunewell KH
    Cell Mol Neurobiol; 2009 Mar; 29(2):273-86. PubMed ID: 18925431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D quantitative structure-activity relationship (QSAR) Models.
    Nicolotti O; Pellegrini-Calace M; Altomar C; Carotti A; Carrieri A; Sanz F
    Curr Med Chem; 2002 Jan; 9(1):1-29. PubMed ID: 11864064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.